FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2610512017> ?p ?o ?g. }

• W2610512017 endingPage "1297553" @default.
• W2610512017 startingPage "1297553" @default.
• W2610512017 abstract "Hedonic and homeostatic hunger represent two different forms of eating: just for pleasure or following energy deprivation, respectively. Consumption of food for pleasure was reported to be associated with increased circulating levels of both the orexigenic peptide ghrelin and some specific endocannabinoids in normal-weight subjects and patients with morbid obesity. To date, the effects of palatable food on these mediators in Prader–Willi syndrome (PWS) are still unknown. To explore the role of some gastrointestinal orexigenic and anorexigenic peptides and endocannabinoids (and some related congeners) in chocolate consumption, we measured changes in circulating levels of ghrelin, cholecystokinin (CCK), peptide YY (PYY), anandamide (AEA), 2-arachidonoyl-glycerol (2-AG), palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) in eight satiated adult PWS patients after consumption of chocolate and, on a separate day, of a non-palatable isocaloric food with the same macronutrient composition. Evaluation of hunger and satiety was also performed by visual analogic scale. The anticipatory phase and the consumption of food for pleasure were associated with decreased circulating levels of PYY. An increase in PEA levels was also observed. By contrast, circulating levels of ghrelin, CCK, AEA, 2-AG and OEA did not differ before and after the exposure/ingestion of either chocolate or non-palatable foods. Hunger and satiety were similar in the hedonic and non-palatable sessions. In conclusion, when motivation to eat is promoted by highly palatable foods, a depressed post-prandial PYY secretion is observed in PWS. Although preliminary, these findings seem to hypothesize a possible role of PYY agonists in the management of PWS patients. Abbreviations: AEA, Anandamide; 2-AG, 2-arachidonoyl-glycerol; CB 1 , cannabinoid receptor type 1; OEA, oleoylethanolamide; PEA, palmitoylethanolamide; PWS: Prader-Willi syndrome; VAS, visual analog scales" @default.
• W2610512017 created "2017-05-12" @default.
• W2610512017 creator A5007484138 @default.
• W2610512017 creator A5022239321 @default.
• W2610512017 creator A5039524421 @default.
• W2610512017 creator A5041905851 @default.
• W2610512017 creator A5042161596 @default.
• W2610512017 creator A5043531512 @default.
• W2610512017 creator A5056765383 @default.
• W2610512017 creator A5056784492 @default.
• W2610512017 creator A5064810373 @default.
• W2610512017 creator A5073170642 @default.
• W2610512017 creator A5079482269 @default.
• W2610512017 date "2017-01-01" @default.
• W2610512017 modified "2023-09-27" @default.
• W2610512017 title "Hedonic eating in Prader–Willi syndrome is associated with blunted PYY secretion" @default.
• W2610512017 cites W1677404691 @default.
• W2610512017 cites W1815206541 @default.
• W2610512017 cites W1847168837 @default.
• W2610512017 cites W1915088265 @default.
• W2610512017 cites W1922423641 @default.
• W2610512017 cites W1976844911 @default.
• W2610512017 cites W1976851391 @default.
• W2610512017 cites W1982940237 @default.
• W2610512017 cites W1987062232 @default.
• W2610512017 cites W1988606404 @default.
• W2610512017 cites W1996677298 @default.
• W2610512017 cites W2003982930 @default.
• W2610512017 cites W2006689363 @default.
• W2610512017 cites W2008854521 @default.
• W2610512017 cites W2009295793 @default.
• W2610512017 cites W2010974521 @default.
• W2610512017 cites W2016294648 @default.
• W2610512017 cites W2024269680 @default.
• W2610512017 cites W2036992242 @default.
• W2610512017 cites W2041107590 @default.
• W2610512017 cites W2047203229 @default.
• W2610512017 cites W2053869844 @default.
• W2610512017 cites W2056611518 @default.
• W2610512017 cites W2057349855 @default.
• W2610512017 cites W2058161128 @default.
• W2610512017 cites W2064185418 @default.
• W2610512017 cites W2069315921 @default.
• W2610512017 cites W2088974721 @default.
• W2610512017 cites W2089699203 @default.
• W2610512017 cites W2090476959 @default.
• W2610512017 cites W2093121188 @default.
• W2610512017 cites W2105825982 @default.
• W2610512017 cites W2106767635 @default.
• W2610512017 cites W2107440671 @default.
• W2610512017 cites W2135010797 @default.
• W2610512017 cites W2137581394 @default.
• W2610512017 cites W2139979797 @default.
• W2610512017 cites W2140203708 @default.
• W2610512017 cites W2141491488 @default.
• W2610512017 cites W2141804323 @default.
• W2610512017 cites W2145146488 @default.
• W2610512017 cites W2148080316 @default.
• W2610512017 cites W2162534744 @default.
• W2610512017 cites W2167311298 @default.
• W2610512017 cites W2186338654 @default.
• W2610512017 cites W2236139676 @default.
• W2610512017 cites W2341432651 @default.
• W2610512017 cites W78447774 @default.
• W2610512017 doi "https://doi.org/10.1080/16546628.2017.1297553" @default.
• W2610512017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5475322" @default.
• W2610512017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28659728" @default.
• W2610512017 hasPublicationYear "2017" @default.
• W2610512017 type Work @default.
• W2610512017 sameAs 2610512017 @default.
• W2610512017 citedByCount "10" @default.
• W2610512017 countsByYear W26105120172018 @default.
• W2610512017 countsByYear W26105120172019 @default.
• W2610512017 countsByYear W26105120172020 @default.
• W2610512017 countsByYear W26105120172021 @default.
• W2610512017 countsByYear W26105120172023 @default.
• W2610512017 crossrefType "journal-article" @default.
• W2610512017 hasAuthorship W2610512017A5007484138 @default.
• W2610512017 hasAuthorship W2610512017A5022239321 @default.
• W2610512017 hasAuthorship W2610512017A5039524421 @default.
• W2610512017 hasAuthorship W2610512017A5041905851 @default.
• W2610512017 hasAuthorship W2610512017A5042161596 @default.
• W2610512017 hasAuthorship W2610512017A5043531512 @default.
• W2610512017 hasAuthorship W2610512017A5056765383 @default.
• W2610512017 hasAuthorship W2610512017A5056784492 @default.
• W2610512017 hasAuthorship W2610512017A5064810373 @default.
• W2610512017 hasAuthorship W2610512017A5073170642 @default.
• W2610512017 hasAuthorship W2610512017A5079482269 @default.
• W2610512017 hasBestOaLocation W26105120171 @default.
• W2610512017 hasConcept C118303440 @default.
• W2610512017 hasConcept C126322002 @default.
• W2610512017 hasConcept C134018914 @default.
• W2610512017 hasConcept C170493617 @default.
• W2610512017 hasConcept C193230392 @default.
• W2610512017 hasConcept C2491326 @default.
• W2610512017 hasConcept C2777205416 @default.
• W2610512017 hasConcept C2777369949 @default.
• W2610512017 hasConcept C2777593968 @default.

• next